Regression of Peyer's patches in Gαi2 deficient mice prior to colitis is associated with reduced expression of Bcl-2 and increased apoptosis

Gut

Volumn 51, Issue 3, 2002, Pages 392-397

  Ohman L ^a   Franzen L ^b   Rudolph, U ^c   Birnbaumer, L ^d   Hörnquist, Elisabeth Hultgren ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b ÖREBRO UNIVERSITY HOSPITAL   (Sweden)

^c UNIVERSITY OF ZURICH   (Switzerland)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; GUANINE NUCLEOTIDE BINDING PROTEIN; INTERLEUKIN 10; PROTEIN BCL 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; COLITIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; ENTERITIS; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; INTESTINE FLORA; KNOCKOUT GENE; MOUSE; NONHUMAN; PEYER PATCH; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TH1 CELL; TH2 CELL; ULCERATIVE COLITIS;

ANIMALS; APOPTOSIS; B-LYMPHOCYTES; COLITIS, ULCERATIVE; FEMALE; GTP-BINDING PROTEINS; INTERFERON TYPE II; MALE; MICE; MICE, INBRED STRAINS; PEYER'S PATCHES; PROTO-ONCOGENE PROTEINS C-BCL-2; T-LYMPHOCYTES;

EID: 0036717877     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.51.3.392     Document Type: Article

References (46)

1. Ulcerative colitis and adenocarcinoma of the colon in G alpha i2-deficient mice
2. Immune activation in the intestinal mucosa before onset of colitis in Gai2-deficient mice
3. G(alpha)i2-deficient mice with colitis exhibit a local increase in memory CD4+ T cells and proinflammatory Th1-type cytokines
4. Mice are protected from Helicobacter pylori infection by nasal immunization with attenuated Salmonella typhimurium phoPc expressing urease A and B subunits
5. Effector and regulatory lymphoid cells and cytokines in mucosal sites
6. Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene
7. The germfree state prevents development of gut and joint inflammatory disease in HLA-B27 transgenic rats
8. Normal luminal bacteria, especially Bacteroides species, mediate chronic colitis, gastritis, and arthritis in HLA-B27/human beta2 microglobulin transgenic rats
9. Open label trial of oral clarithromycin in active Crohn's disease
10. Controlled trial of metronidazole treatment for prevention of Crohn's recurrence after ileal resection
11. Effect of faecal stream diversion on recurrence of Crohn's disease in the neoterminal ileum
12. Early lesions of recurrent Crohn's disease caused by infusion of intestinal contents in excluded ileum
13. Tolerance exists towards resident intestinal flora but is broken in active inflammatory bowel disease (IBD)
14. Decreased Bax expression by mucosal T cells favours resistance to apoptosis in Crohn's disease
15. Lamina propria T cells in Crohn's disease and other gastrointestinal inflammation show defective CD2 pathway-induced apoptosis
16. Regulation of T-cell apoptosis in inflammatory bowel disease: To die or not to die, that is the mucosal question
17. CD95 (APO-1/Fas)-mediated apoptosis in colon epithelial cells: A possible role in ulcerative colitis
18. High Fas ligand expression on lymphocytes in lesions of ulcerative colitis
19. Proliferation and apoptosis of lamina propria CD4+ T cells from scid mice with inflammatory bowel disease
20. Gut-associated lymphoid tissues in ulcerative colitis
21. In vitro methods in cell-mediated and tumor immunity
22. Cholera toxin adjuvant greatly promotes antigen priming of T cells
23. Peyer's patch organogenesis as a programmed inflammation: A hypothetical model
24. A chemokine-driven positive feedback loop organizes lymphoid follicles
25. Critical role for beta7 integrins in formation of the gut-associated lymphoid tissue
26. Phosphorylation of Bcl2 and regulation of apoptosis
27. Rescue of ileal Peyer's patch B cells from apoptosis is associated with the induction of Bcl-2 expression
28. Increased mucosal B-lymphocyte apoptosis during polymicrobial sepsis is a Fas ligand but not an endotoxin-mediated process
29. Lipopolysaccharide causes atrophy of Peyer's patches and an increased expression of CD28 and B7 costimulatory ligands
30. Selective induction of Th2 cells in murine Peyer's patches by oral immunization
31. The in vitro production of cytokines by mucosal lymphocytes immunized by oral administration of keyhole limpet hemocyanin using cholera toxin as an adjuvant
32. Regulation of murine lymphokine production in vivo. III. The lymphoid tissue microenvironment exerts regulatory influences over T helper cell function
33. Freshly isolated Peyer's patch, but not spleen, dendritic cells produce interleukin 10 and induce the differentiation of T helper type 2 cells
34. IL-4 inhibits apoptosis and prevents mitochondrial damage without inducing the switch to necrosis observed with caspase inhibitors
35. Selective up-regulation of phosphatidylinositol 3′-kinase activity in Th2 cells inhibits caspase-8 cleavage at the death-inducing complex: A mechanism for Th2 resistance from Fas-mediated apoptosis
36. Gamma interferon induces Fas-dependent apoptosis of Peyer's patch T cells in mice following peroral infection with Toxoplasma gondii
37. Control of target cell survival in thyroid autoimmunity by T helper cytokines via regulation of apoptotic proteins
38. Studies on nucleotide and receptor regulation of Gi proteins: Effects of pertussis toxin
39. Pertussis infection and vaccination induces Th1 cells
40. Interleukin-12 is produced by macrophages in response to live or killed Bordetella pertussis and enhances the efficacy of an acellular pertussis vaccine by promoting induction of Th1 cells
41. Elicitation of experimental allergic encephalomyelitis (EAE) in mice with the aid of pertussigen
42. The requirement for pertussis to induce EAU is strain-dependent: B10.RIII, but not B10.A mice, develop EAU and Th1 responses to IRBP without pertussis treatment
43. Primary role for Gi protein signaling in the regulation of interleukin 12 production and the induction of T helper cell type 1 responses
44. Role of appendix in the development of inflammatory bowel disease in TCR-alpha mutant mice